SAM, JSA Advised On CORONA Remedies’ ₹655 Cr IPO Pharmaceuticals December 25, 2025 Capital Markets – Equity
CAM, SAM, Sidley, S&R Advised On IPAMC’s ₹10,600 Cr IPO Asset Management & Funds December 24, 2025 Capital Markets – Equity
SAM, CAM, Latham & Watkins Advised On Groww’s $748 Million IPO Fintech & Financial Services November 14, 2025 Capital Markets – Equity
Shardul Amarchand Advises Underwriters In IPO By Niva Bupa Health Insurance For USD 260 Million Pharmaceutical and Healthcare November 21, 2024 Capital Markets – Equity
